The FDA announced on March 1, 2022, that Edwards Lifesciences, LLC is recalling the FORE-SIGHT ELITE Absolute Tissue Oximeter because StO2 values may be inaccurately low. This hazard could lead to unintended or inappropriate treatment for patients.
How to tell if you have it
- Brand: Edwards Lifesciences
- Product: FORE-SIGHT ELITE Absolute Tissue Oximeter, REF: 01-06-3000
- Model Number: 01-06-3000
- UDI: 10609538630009
- Serial numbers: All Serial numbers
- Contents: Monitor 1 EA., Accessory Kit 1 EA.
- Units affected: 402 units
The hazard
The StO2 values may be inaccurately low when using either the FORE-SIGHT ELITE Tissue Oximeter Module or the FORE-SIGHT ELITE Absolute Tissue Oximeter Monitor with the Fore-Sight Elite large sensor in certain somatic locations, specifically arms and legs. While the directional trend remains accurate, it may have a larger magnitude change. Low StO2 values may lead to unintended or inappropriate treatment.
Context
GovInfoNow's records show Edwards Lifesciences, LLC has had 25 other recalls on record since July 6, 2017. Recent brand recalls include the March 27, 2026, EVOQUE Tricuspid Delivery System labeling update and the May 14, 2025, FEM-FLEX II Femoral Arterial Cannula exposed wire hazard. Other recent recalls of similar products include the NOxBOXi Nitric Oxide Delivery System (September 14, 2026) and the LH One Step Ovulation Test Device (November 22, 2025).